Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain

Neurochem Res. 1995 Dec;20(12):1503-10. doi: 10.1007/BF00970600.

Abstract

The present study has examined whether MAO-B has a role in DA metabolism in the primate CNS in situ. Eleven macaques (macaca facicularis) were used in this study to examine the effects of (-)-deprenyl (1 mg/kg, i.v., 2 and 24 hours). (-)-Deprenyl administration completely and selectively blocked MAO-B activity and blocked DA metabolism in the caudate nucleus and frontal cortex. DA metabolism in the substantia nigra was not affected by MAO-B inhibition. Changes in DA metabolism were accompanied by changes in 5-hydroxytryptamine (5HT) turnover: 5-hydroxyindole acetic acid (5HIAA) levels increased in the caudate and decreased in the frontal cortex. Levels of 2-phenylethylamine (PE), a putative modulator of dopaminergic transmission, were increased by MAO-B inhibition in all three brain regions examined. It is concluded that in some regions of the primate brain, in contrast to the rat, MAO-B has an important role in DA metabolism.

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Brain / drug effects*
  • Brain / metabolism*
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / metabolism
  • Dopamine / metabolism*
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism
  • Homovanillic Acid / metabolism
  • Hydroxyindoleacetic Acid / metabolism
  • Macaca fascicularis
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Phenethylamines / metabolism
  • Selegiline / pharmacology*
  • Serotonin / metabolism

Substances

  • Monoamine Oxidase Inhibitors
  • Phenethylamines
  • 3,4-Dihydroxyphenylacetic Acid
  • Selegiline
  • phenethylamine
  • Serotonin
  • Hydroxyindoleacetic Acid
  • Monoamine Oxidase
  • Dopamine
  • Homovanillic Acid